 |
The
Bendy Bus: a video viral |
| |
After some ‘gruelling’ auditions,
a long day’s filming and numerous edits, Diabetes UK is pleased to announce that we have
successfully completed our first video highlighting the issues
for people with Type 1 diabetes (Diabetes UK) |
| |
|
|
DIAMAP
- Invitation to diabetes researchers |
| |
Invitation to diabetes researchers to participate
in major new European project to map diabetes research (NDST, UK) |
| |
|
|
ADVANCE
helps clarify ACCORD mortality mystery but questions remain |
| |
There has been great interest in ADVANCE following
surprising results from the ACCORD (Action to Control Cardiovascular
Risk in Diabetes) study which was terminated prematurely earlier
this year due to a 22% increase in all cause mortality in patients
whose blood glucose was aggressively controlled using regimens
which included thiazolidinediones (PharmaTimes) |
| |
|
|
Merck
Serono's Glucophage(R) Powder for Oral Solution in Sachet Receives
Positive Opinion for Approval in Europe |
| |
Glucophage® Powder for Oral
Solution in Sachet (metformin hydrochloride in 500mg, 850mg and
1000mg strengths) has received a positive opinion recommending
approval for the first-line treatment of type 2 diabetes through
a Decentralized Procedure (DCP) with France as the Reference Member
State (BioSpace) |
| |
|
|
Novartis
presents new drug data |
| |
New data show Galvus – an
oral dipeptidyl peptidase 4 (DPP-4) inhibitor for type 2 diabetes – can lower blood sugar without the risk of producing hypoglycaemic attacks (Pharmacy
Europe) |
| |
|
|
Uncovering
Glucose Abnormalities in People With Hepatitis C Infection |
| |
Should Oral Glucose Tolerance Test Become a
Standard of Care? (American Journal of Gastroenterology) |
| |
|
|
Pathogenesis
of type 2 diabetes: tracing the reverse route from cure to cause |
| |
The metabolic abnormalities of type 2 diabetes
can be reversed reproducibly by bariatric surgery. By quantifying
the major pathophysiological abnormalities in insulin secretion
and insulin action after surgery, the sequence of events leading
to restoration of normal metabolism can be defined (Diabetologia) |
| |
|
|
Real-Time
Glucose Sensors in Children and Adolescents with Type-1 Diabetes
- Mini review |
| |
The results of our ongoing international pediatric
ONSET trial will show the impact of this technology on learning
to live with diabetes by having the biofeedback of glucose excursions
from the onset of diabetes (Hormone Research) |
| |
|
|
Assessing
the Cardiovascular Safety of Diabetes Therapies |
| |
Cardiovascular-outcome trials are not required
at the time of approval of diabetes drugs. Since conducting such
a trial is expensive and can take years, some worry that requiring
an outcome trial before marketing would delay the availability
or inhibit the development of new agents. Yet delay in obtaining
these data could put many patients at undue risk, and physicians
and patients must choose drugs without knowledge of the risk–benefit balance (NEJM, USA) |
| |
|
|
10-Year
Follow-up of Intensive Glucose Control in Type 2 Diabetes |
| |
Despite an early loss of glycemic differences,
a continued reduction in microvascular risk and emergent risk reductions
for myocardial infarction and death from any cause were observed
during 10 years of post-trial follow-up (NEJM, USA) |
| |
|
|
1st
World Congress on Interventional Therapies for Type 2 Diabetes |
| |
A comprehensive and multidisciplinary forum
where leaders in the global health community will conduct an organized
review and discussion of the latest scientific data and theories
(Interventional Diabetology) |
| |
|
